KIAA ELISA kits are designed to measure levels of KIAA proteins in biological samples. The KIAA gene family includes various proteins with roles in cellular processes such as cell signaling, proliferation, and differentiation. Accurate measurement of these proteins can provide insights into their functions and involvement in diseases, including cancer and neurodegenerative disorders.
Components
- Coated Microplate:
- A 96-well plate pre-coated with antibodies specific to the KIAA protein of interest. This allows the KIAA proteins in the sample to be captured on the plate.
- Standards:
- Recombinant or purified KIAA proteins with known concentrations used to create a standard curve for quantifying KIAA levels in samples.
- Detection Antibody:
- A secondary antibody specific to the KIAA protein, typically conjugated to an enzyme such as horseradish peroxidase (HRP) or alkaline phosphatase (AP) for detection.
- Substrate Solution:
- Contains a substrate that reacts with the enzyme linked to the detection antibody, producing a color change proportional to the amount of KIAA protein present.
- Stop Solution:
- An acid solution that halts the enzyme reaction and stabilizes the color for measurement.
- Wash Buffer:
- Used to wash away unbound substances and reduce background noise, ensuring that only specifically bound KIAA proteins are measured.
Technical Considerations
- Sensitivity:
- The lowest concentration of KIAA protein detectable by the assay.
- Specificity:
- The ability of the kit to specifically detect the KIAA protein of interest without cross-reacting with other proteins.
- Reproducibility:
- Consistency of results across different assays and sample conditions.
- Interferences:
- Potential effects of other substances in the sample that might impact assay accuracy.
Applications
- Research: Studying the role of KIAA proteins in cellular processes and their involvement in various diseases.
- Clinical Diagnostics: Monitoring KIAA protein levels in diseases such as cancer or neurodegenerative disorders where these proteins may be implicated.
- Drug Development: Evaluating the effects of potential therapeutic agents targeting KIAA proteins or their pathways.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|